Vemurafenib/dabrafenib and trametinib

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|306-5251|4|765-767

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.306-5251, Iss.4, 2015-10, pp. : 765-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vemurafenib/dabrafenib and trametinib

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 765-767

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful switch to dabrafenib after vemurafenib‐induced toxic epidermal necrolysis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1454-1455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. : e31-e32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 2, 2018-02 ,pp. : e35-e36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dabrafenib‐induced pemphigoid‐like reaction

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 43, Iss. 2, 2018-03 ,pp. : 222-224

John Wiley & Sons Inc

Access to resources Recommend Favorite